Ambu® AuraGain™
Ambu® AuraGain™ is a medical device with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia
Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients
A Comparison of Ambu® AuraGain™ Laryngeal Mask Airway and I-gel in Adult
Effect of the Neck Extension on Blind Intubation Via Ambu® AuraGain™
Ambu®AuraGain™ Versus I-gel® in Obese Patients
Clinical Trials (8)
Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia
Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients
A Comparison of Ambu® AuraGain™ Laryngeal Mask Airway and I-gel in Adult
Effect of the Neck Extension on Blind Intubation Via Ambu® AuraGain™
Ambu®AuraGain™ Versus I-gel® in Obese Patients
RCT:Oropharyngeal Leak Pressure (OLP) - Ambu AuraGain vs LMA Supreme
A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients
Ambu AuraOnce Versus Ambu AuraGain LM in Children
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8